Talar-Wojnarowska R, Gasiorowska A, Olakowski M, Lampe P, Smolarz B, Romanowicz-Makowska H, Malecka-Panas E. Role of cyclooxygenase-2 gene polymorphisms in pancreatic carcinogenesis. World J Gastroenterol 2011; 17(36): 4113-4117 [PMID: 22039326 DOI: 10.3748/wjg.v17.i36.4113]
Corresponding Author of This Article
Renata Talar-Wojnarowska, MD, PhD, Department of Digestive Tract Diseases, Medical University of Lodz, Kopcinskiego 22, 90-153 Lodz, Poland. renata.talar-wojnarowska@umed.lodz.pl
Article-Type of This Article
Brief Article
Open-Access Policy of This Article
This article is an open-access article which was selected by an in-house editor and fully peer-reviewed by external reviewers. It is distributed in accordance with the Creative Commons Attribution Non Commercial (CC BY-NC 4.0) license, which permits others to distribute, remix, adapt, build upon this work non-commercially, and license their derivative works on different terms, provided the original work is properly cited and the use is non-commercial. See: http://creativecommons.org/licenses/by-nc/4.0/
World J Gastroenterol. Sep 28, 2011; 17(36): 4113-4117 Published online Sep 28, 2011. doi: 10.3748/wjg.v17.i36.4113
Role of cyclooxygenase-2 gene polymorphisms in pancreatic carcinogenesis
Renata Talar-Wojnarowska, Anita Gasiorowska, Marek Olakowski, Pawel Lampe, Beata Smolarz, Hanna Romanowicz-Makowska, Ewa Malecka-Panas
Renata Talar-Wojnarowska, Anita Gasiorowska, Ewa Malecka-Panas, Department of Digestive Tract Diseases, Medical University, 22 Kopcinskiego, 90-153 Lodz, Poland
Marek Olakowski, Paweł Lampe, Department of Digestive Tract Surgery, Silesian Medical University, 14 Medykow, 40-752 Katowice, Poland
Beata Smolarz, Hanna Romanowicz-Makowska, Laboratory of Molecular Genetics, Institute of Polish Mother’s Memorial Hospital, 281/289 Rzgowska, 93-338 Lodz, Poland
Author contributions: Talar-Wojnarowska R and Gasiorowska A provided the protocols and performed the research; Olakowski M and Lampe P provided the collection of human material and analyzed the data; Smolarz B and Romanowicz-Makowska H carried out the molecular analysis; and Talar-Wojnarowska R and Malecka-Panas E designed the study and wrote the paper.
Correspondence to: Renata Talar-Wojnarowska, MD, PhD, Department of Digestive Tract Diseases, Medical University of Lodz, Kopcinskiego 22, 90-153 Lodz, Poland. renata.talar-wojnarowska@umed.lodz.pl
Telephone: +48-42-6786480 Fax: +48-42-6786480
Received: December 20, 2010 Revised: March 26, 2011 Accepted: April 2, 2011 Published online: September 28, 2011
Abstract
AIM: To evaluate the clinical significance of -765G/C and -1195G/A cyclooxygenase-2 (COX-2) gene polymorphisms in patients with pancreatic cancer (PC).
METHODS: The study included 201 patients: 85 with PC and 116 healthy controls. -765G/C and -1195G/A COX-2 gene polymorphisms were studied in DNA isolated from blood samples. The associations of the analyzed genotypes and clinical data at diagnosis were evaluated.
RESULTS: We found an increased frequency of the homozygous -1195AA COX-2 genotype in patients with PC (53.7%) compared with the control group (21%) (P < 0.01). In contrast, the distribution of genotype and allele frequencies of the -765G/C COX-2 polymorphism in the PC patients were not different from those in control groups. A correlation between presence of homozygous -1195AA COX-2 genotype and tumor size > 3 cm was observed (P < 0.05). Analyzed polymorphisms were unrelated to the patients’ sex and age, nor to the presence of regional or distant metastases.
CONCLUSION: These preliminary results indicate that the -1195G/A COX-2 polymorphism may play an important role in PC prognosis and carcinogenesis.
